Phil Franchina, Author at American Parkinson Disease Association

LEVODOPA AND THE FUTURE OF PARKINSON’S RESEARCH

Posted on September 20, 2021 by Phil Franchina

Tremors, issues with balance, and slowness are just some of the trademark...see more symptoms of Parkinson’s disease (PD). PD is caused by a loss of critical neurons in the brain that use dopamine to communicate. That’s where levodopa comes in — as a way to replenish that dopamine and […]

PARKINSON’S DISEASE IN A POST-PANDEMIC WORLD: WHAT’S NEXT?

Posted on September 20, 2021 by Phil Franchina

Vaccination rates against COVID-19 are on the rise and reaching promising...see more levels across the nation. A return to “normal” is something we’ve all been looking forward to, and we hope to continue to head in that direction even as variants emerge and give us pause. As more […]

Pushing for Progress: American Parkinson Disease Association Funding To Accelerate Scientists’ Pursuit for Answers

Posted on August 31, 2021 by Phil Franchina

From biomarker development to the...see more use of sono-optogenetics, $1.85 million in innovative research to be funded for 2021– 2022 year NEW YORK, NY, September 1, 2021 – The American Parkinson Disease Association (APDA) has just awarded $1.85 million to support cutting-edge […]

“ASK THE DOCTOR” with Dr. Rebecca Gilbert

Posted on June 18, 2021 by Phil Franchina

Q. My husband experiences big differences in the time it takes for...see more a dose of carbidopa/levodopa to work. It may take anywhere from 20 minutes to 2.5 hours! That makes it very difficult to know when to take the medication when we are going out. A. This problem […]

WHAT’S HAPPENING AT APDA?

Posted on June 18, 2021 by Phil Franchina

Dr. Gilbert Hosts: Genetics and PD With Dr. Clemens Scherzer Genetic mutations, genetic testing, genetic...see more research — it’s fascinating stuff! Dr. Clemens Scherzer recently sat down with Dr. Rebecca Gilbert for an episode of Dr. Gilbert Hosts to discuss genetics and PD ― but don’t worry if you missed it! You […]

SUMMER VACATION: TAKING YOUR PD ON THE ROAD

Posted on June 18, 2021 by Phil Franchina

Ready for a getaway? Whether you’re venturing near or far, if...see more you have PD or are traveling with someone who does, make sure you’re prepared. As more people get vaccinated against COVID-19, some travel restrictions are easing up*. Even still, it’s important to continue practicing good habits […]

Healthy Today, Happy Tomorrow: Staying Strong with Parkinson’s Disease

Posted on June 18, 2021 by Phil Franchina

A Parkinson’s disease (PD) diagnosis often comes with a unique...see more set of challenges ― but by getting active, eating better, and making mental health a priority, people facing PD can improve their overall health. Exercise Getting outside and exercising is a great way for people affected […]

EXCITING GENETIC DISCOVERIES FUNDED BY APDA

Posted on May 6, 2021July 13, 2023 by Phil Franchina

May 6, 2021 In an exciting new study, researchers at the APDA Center for Advanced Research at Brigham and...see more Women’s Hospital studied the genetic changes that increase the rate of progression of Parkinson’s disease (PD). Currently, there are many genes that are associated with an increased risk of developing PD. But once a person has […]

New Clinical Use for Gocovri

Posted on May 3, 2021July 13, 2023 by Phil Franchina

Adamas announced that the Food and Drug Administration (FDA) approved Gocovri for a second indication – as an add-on...see more treatment to carbidopa/levodopa in Parkinson’s disease (PD) patients who are experiencing OFF episodes. Previously, Gocovri was only approved for treatment of Levodopa-induced dyskinesias. You can learn more about managing dyskinesias and OFF episodes in this webinar. […]

Giving Monthly Means Daily Support

Posted on April 12, 2021April 28, 2021 by Phil Franchina

Giving Monthly Means Daily Support BECOME A MONTHLY DONOR TODAY AND SHOW YOUR SUPPORT FOR PEOPLE WITH PARKINSON’S DISEASE...see more (PD) ✓ It’s fast ✓ It’s easy ✓ And you’ll make a difference every month! “My husband, Armando, has Parkinson’s disease. It is important for us to do our part, and giving a gift monthly makes […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Ways to Give

LEVODOPA AND THE FUTURE OF PARKINSON’S RESEARCH

PARKINSON’S DISEASE IN A POST-PANDEMIC WORLD: WHAT’S NEXT?

Pushing for Progress: American Parkinson Disease Association Funding To Accelerate Scientists’ Pursuit for Answers

“ASK THE DOCTOR” with Dr. Rebecca Gilbert

WHAT’S HAPPENING AT APDA?

SUMMER VACATION: TAKING YOUR PD ON THE ROAD

Healthy Today, Happy Tomorrow: Staying Strong with Parkinson’s Disease

EXCITING GENETIC DISCOVERIES FUNDED BY APDA

New Clinical Use for Gocovri

Giving Monthly Means Daily Support

New blood test could 'revolutionize' early detection of Parkinson's disease

Supporters focus on empowerment, education this awareness month

'Breakthrough' deep brain stimulation device for Parkinson's to make clinical debut

She was diagnosed with Parkinson’s at 27. These were her warning signs.

AMERICAN PARKINSON DISEASE ASSOCIATION TO EDUCATE AND EMPOWER DURING PARKINSON’S DISEASE AWARENESS MONTH

AMERICAN PARKINSON DISEASE ASSOCIATION FREE TWO-DAY VIRTUAL CONFERENCE RETURNS TO EDUCATE, EMPOWER, AND ENGAGE THE PD COMMUNITY

Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON'S ACT BECOMING LAW

FDA Approves New Adaptive DBS System

ONAPGO: A Newly-Approved Medication for OFF Periods in Parkinson’s

EPA Bans TCE, a Solvent Linked to PD

Vyalev: A Newly-Approved Medication for Parkinson’s Disease Motor Fluctuations

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!